Upload File

powerpoint presentation · pdf file133 100 exe: exenatide extended release; iglar: insulin...

  • Home
  • Documents
  • PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
120

Upload: trinhngoc

Post on 10-Feb-2018

218 views

Category:

Documents


0 download

Report

TRANSCRIPT

Page 1: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 2: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 3: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 4: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 5: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 6: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 7: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 8: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 9: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 10: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 11: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 12: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 13: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 14: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 15: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 16: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 17: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 18: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 19: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 20: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 21: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 22: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 23: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 24: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 25: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 26: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 27: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 28: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 29: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 30: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 31: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 32: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 33: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 34: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 35: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 36: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 37: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 38: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 39: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 40: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 41: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 42: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 43: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 44: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 45: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 46: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 47: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 48: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 49: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 50: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 51: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 52: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 53: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 54: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 55: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 56: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 57: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 58: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 59: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 60: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 61: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 62: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 63: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 64: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 65: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 66: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 67: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 68: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 69: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 70: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 71: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 72: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 73: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 74: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 75: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 76: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 77: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 78: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 79: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 80: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 81: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 82: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 83: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 84: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 85: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 86: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 87: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 88: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 89: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 90: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 91: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 92: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 93: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 94: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 95: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 96: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 97: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 98: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 99: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 100: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 101: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 102: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 103: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 104: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 105: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 106: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 107: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 108: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 109: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 110: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 111: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 112: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,

ONSCREEN BACK-UP SLIDES

Page 113: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 114: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 115: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 116: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 117: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 118: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 119: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 120: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,

Novo Nordisk - AUSTRALIAN PRODUCT …...AUSTRALIAN PRODUCT INFORMATION OZEMPIC® (semaglutide) solution for injection 1. NAME OF THE MEDICINE semaglutide (rys) 2. QUALITATIVE AND QUANTITATIVE

PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION … › content › dam › Canada › AFFILIATE › ... · 2 days ago · RYBELSUS® (semaglutide tablets) Product Monograph Page 1

Population Pharmacokinetics of Semaglutide for …...with type 2 diabetes [6]. Of the covariates investigated, only body weight had a relevant effect on the exposure of semaglutide

King s Research Portal · PDF file133 according to the total number of ... 145 None of the STAT5 mutants exhibited histological ... 149 individuals presented a loss of glomerular structure,

Oral Semaglutide for the treatment of type 2 diabetes mellitus · 2018-08-29 · treatment of type 2 diabetes mellitus SUMMARY Semaglutide is in clinical development as an oral treatment

Archiving SAP Data—Practical Guide - Amazon S3 · PDF file133 Chapter 3 Like for data storage, you have many selection options available for accessing archived data. Depending on

The Sweetness of Pharmacotherapy · 2020. 8. 10. · CV Effects ASCVD: benefit in liraglutide>semaglutide>exenatide ER HF: Neutral Renal Dosing Progression of DKD: Benefit: liraglutide

Novo Nordisk WEGOVY- semaglutide injection, solution

Semaglutide versus dulaglutide once weekly in patients ...diabetestoolbox.ca/pdf/Etudes_AHNI/Sustain_7_pub.pdf · an interactive web-response system to once a week treatment with

Clinical Pharmacokinetics of Oral Semaglutide: Analyses of ......R. V. Overgaard et al. anti-diabetic agents [3 –10]. Oral semaglutide has also been demonstrated to be well tolerated

Advances in GLP-1 treatment: focus on oral semaglutide

Novo Nordisk a focused healthcare company...Novo Nordisk® Diabetes: • Semaglutide 2.0 mg phase 3b trial successfully completed • Once-weekly insulin icodec phase 3 trial programme

Matter— Properties and - · PDF file133 Properties and Changes of Matter Make the following Foldable to help you organize types of properties and changes into groups based on their

Efficacy, Safety and Tolerability of Oral ... - Diabetes · Patients with type 2 diabetes uncontrolled on insulin, ± metformin, were randomized to oral semaglutide 3 mg (N=184),

Australian public assessment report for Semaglutide

EL “REGIONALISMO POLÍTICO NO PARTIDISTA” EN ANA AD … file133 el “regionalismo polÍtico no partidista” en ana ad ciud ¿repolitizaciÓn actual: el chile o expresiÓn neoliberal?

Mozart – Symphony 41 · PDF file133 134 135 136 137 138 139 140. 141 142 143 144 145 146 147 148. 9

Staff Selection Commission (SR) · PDF file133 8006004388 thammannagari muni jahnavi 6 134 8006004481 chinnabbagari udayeswar reddy 6 135 8006004526 meduru leela ... 326 8008008919

Assessment report - ema.europa.eu · Name of the medicinal product: Ozempic Applicant: Novo Nordisk A/S Novo Allé 1 DK-2880 Bagsvaerd Denmark Active substance: semaglutide International

Effects of once-weekly semaglutide vs once-daily canagliflozin on … · 2020-02-03 · Trial design and participants The trial design for SUSTAIN 8 (ClinicalTrials.gov registration

FDA Approval Information...a good candidate for EMPA exenatide extended . Oral Semaglutide Monograph . Projected Place in Therapy . Until more information is available regarding cardiovascular

The GLP-1 Analogs Liraglutide and Semaglutide Reduce ... · The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE / and LDLr / Mice by a Mechanism That Includes

131 Les artistes, collaborateurs du capital, cinquième ... file133 Les artistes, collaborateurs du capital, cinquième colonne, ou résistance ouverte ? Åbäke My Lunch with Bianca

Matter— Properties and - North · PDF file133 Properties and Changes of Matter Make the following Foldable to help you organize types of properties and changes into groups based

Reference ID: 4190425including medullary thyroid carcinoma (MTC), in humans as the human relevance of semaglutide-induced rodent thyroid C-cell tumors has not been determined (5.1,

UNIVERSITY OF PENNSYLVANIA RESEARCH SUBJECT … · 2019. 8. 6. · Version: 1.0 US (EN) Official name of the study: SELECT – Semaglutide effects on cardiovascular outcomes in people

MAGAZINE - Novo Nordisk€¦ · 13/11/2017  · MAGAZINE CAMILLA SYLVEST JOINS EXECUTIVE MANAGEMENT NEW INTERESTING RESULTS WITH SEMAGLUTIDE VICTOZA® APPROVED IN THE US AND THE EU

MEMORIAL U0RAAY vwsmao, NJ. THE WESTFIELD LEADER · offensive Itoa *'fa. what; makes aw ruMang attack go." Dave TomatoMi, Dave Pryor, Rick Sampson, John Iglar and Jim HiWitiell along

Attachment: Product Information for Semaglutide · Web viewAttachment 1: AusPAR - Ozempic – semaglutide - Novo Nordisk Pharmaceuticals Pty Ltd - PM-2018-02748-1-5 FINAL 30 October

Knowledge and Practices of Family and Emergency Physicians in … · 2017. 11. 3. · Dr. Karl Iglar, and Dr. Carlos Quinonez. ... 4.2.1 Overprescribing Index (OPI) ... as patients

Real-World Use of Once-Weekly Semaglutide in Type 2

A qos adaptive routing scheme (iglar) for highly dynamic

PUBLIC EMPLOYEES' RETIREMENT SYSTEM October 17, 2018 …...English, Deborah Ellen 07/18 5 Middlesex County Iglar, Marcella E 04/18 5 Hunterdon Co Board Social Serv Lekhrajmal, Antono

A Network Meta-Analysis Comparing Semaglutide Once-Weekly … · 2018. 6. 2. · data were synthesized using an NMA and a Bayesian framework. Results: Four trials, identified from

VME Extension Handles - Pixus · PDF file133 Perfect Handling Solutions With VME64 Extension Handles Injector/extractor handle for insertion and removal of connectors with a large